Get started
Author

Swetha Addanki

Observed names: A. Swetha, Addanki Swetha
ORCID: 0000-0001-5640-0554
Observed ORCID: 0000-0001-5640-0554
OpenAlex ID: A5067538497
Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations
2021 · Ramya kuber B, Swetha Addanki · Future Journal of Pharmaceutical Sciences · 14
PDF
A new stability indicating RP-UPLC method for simultaneous estimation of Doravirine, Lamivudine and Tenofovir disoproxil fumarate in bulk and their combined pharmaceutical formulation
2021 · Swetha Addanki, B. Ramya Kuber · Future Journal of Pharmaceutical Sciences · 10
PDF
New Stability Indicating RP-UPLC Method for Simultaneous Estimation of Telmisartan and Azelnidipine in Bulk and Combined Bilayer Film-Coated Tablet Dosage Form
2023 · Addanki Swetha, Kuber B. Ramya · Pharmaceutical Chemistry Journal · 4
A Novel Stability Indicating RP-HPLC Analytical Method Development and Validation for the Determination of Tepotinib in Bulk and Pharmaceutical Dosage Form
2025 · Ramya Kuber Banoth, Poojitha Nalluri, et al. · Research Journal of Pharmacy and Technology · 1
Policy Reforms and Legal Frameworks in Disability Rights
2026 · Swetha Addanki, Swathi Nalla, et al. · SpringerBriefs in modern perspectives on disability research.
Technological Advancements in Disability Support
2026 · Swathi Nalla, Swetha Addanki, et al. · SpringerBriefs in modern perspectives on disability research.
Novel Stability-Indicating RP-HPLC Method for Estimation of Bexagliflozin in Bulk and Pharmaceutical Dosage form
2025 · A. Swetha, K. Supraja, et al. · Research Journal of Pharmacy and Technology
Works count: 7
Citation count: 29
H-index: 3
I10-index: 2
Year
Topic
Type